Originally published In Press as doi:10.1074/jbc.M206355200 on September 3, 2002
J. Biol. Chem., Vol. 277, Issue 45, 43319-43326, November 8, 2002
In Vivo Regulation of Phosphoinositide 3-Kinase in
Retina through Light-induced Tyrosine Phosphorylation of the Insulin
Receptor
-Subunit*
Raju V. S.
Rajala
§¶,
Mark E.
McClellan
§,
John D.
Ash
§
, and
Robert E.
Anderson
§
**
From the Departments of
Cell Biology,
Ophthalmology, and ** Biochemistry and
Molecular Biology, University of Oklahoma Health Sciences Center,
Oklahoma City, Oklahoma 73104 and the § Dean A. McGee Eye Institute, Oklahoma City, Oklahoma 73104
Received for publication, June 26, 2002, and in revised form, August 18, 2002
 |
ABSTRACT |
Recently, we have shown that phosphoinositide
3-kinase (PI3K) in bovine rod outer segment (ROS) is activated in
vitro by tyrosine phosphorylation of the C-terminal tail of the
insulin receptor (Rajala, R. V. S., and Anderson, R. E. (2001) Invest. Ophthal. Vis. Sci. 42, 3110-3117).
In this study, we have investigated the in vivo mechanism
of PI3K activation in the rodent retina and report the novel finding
that light stimulates tyrosine phosphorylation of the
-subunit of
the insulin receptor (IR
) in ROS membranes, which leads to the
association of PI3K enzyme activity with IR
. Retinas from light- or
dark-adapted mice and rats were homogenized and immunoprecipitated with
antibodies against phosphotyrosine, IR
, or the p85 regulatory
subunit of PI3K, and PI3K activity was measured using
PI-4,5-P2 as substrate. We observed a
light-dependent increase in tyrosine phosphorylation of
IR
and an increase in PI3K enzyme activity in isolated ROS and in
anti-phosphotyrosine and anti-IR
immunoprecipitates of retinal
homogenates. The light effect was localized to photoreceptor neurons
and is independent of insulin secretion. Our results suggest that light
induces tyrosine phosphorylation of IR
in outer segment membranes,
which leads to the binding of p85 through its N-terminal Src homology 2 domain and the generation of PI-3,4,5-P3. We suggest that
the physiological role of this process may be to provide
neuroprotection of the retina against light damage by activating
proteins that protect against stress-induced apoptosis.
 |
INTRODUCTION |
Many cell proliferation and cell survival pathways are
initiated upon activation of tyrosine kinase receptors, which transduce their signals by recruiting a variety of cytoplasmic signaling proteins
(1, 2). Many of the signaling proteins contain phosphotyrosine binding
domains, Src homology 2 (SH2)1 domains, and Src
homology 3 (SH3) domains, which are involved in mediating
protein-protein interactions (4, 5). The
phosphotyrosine-dependent interaction between different
phosphotyrosine binding and SH2 domain-containing proteins with
activated receptors initiates cellular changes that take place in
response to a wide range of extracellular signals (2).
One of the SH2 domain-containing proteins, phosphoinositide
3-kinase (PI3K), consists of an ~85-kDa regulatory subunit (p85) and
a ~110-kDa catalytic subunit (p110), the latter being responsible for
the phosphorylation of phosphoinositides at the D3 position and of
serine residues in proteins (7, 8). The p85 subunit contains an SH3 domain capable of binding to proline-rich sequences, a
p110 binding domain, and two SH2 domains. PI3K was initially found to
be associated with middle-T/pp60c-Src (9), pp60v-Src, and
platelet-derived growth factor receptors in both normal and transformed
NIH3T3 fibroblast cells (10, 11). PI3K activity increases in response
to platelet-derived growth factor binding to its receptor, in large
part because the p85-p110 complex is translocated from the
cytosol to the plasma membrane, by the direct binding of the p85 SH2
domain to tyrosine-phosphorylated sites on the receptor (12, 13).
PI3K activity is also regulated by activated receptor-tyrosine kinase
substrates such as the insulin receptor substrate-1 (5). Thus,
substantial evidence exists suggesting that the Class I p85-p110
complex of PI3K is a common element of numerous signaling pathways
involving a large number of tyrosine kinases (14-16) and that a
variety of stimuli can trigger distinct and specific biological
responses in different cell types.
We have reported that bovine rod outer segments (ROS) contain a Class I
p85-p110 enzyme complex that is more active in light-adapted retinas
in vitro (17) and can be activated by tyrosine
phosphorylation of proteins in these membranes (18). We have identified
a mechanism for regulation of PI3K activity in bovine photoreceptor
cells through tyrosine phosphorylation of the insulin receptor
-subunit (IR
) in vitro (19). The activation is
mediated through direct binding of the N-terminal SH2 domain of p85
subunit of PI3K to the tyrosine-phosphorylated C terminus of the
insulin receptor (19). The role of light in PI3K activation in
vivo has not been investigated, although we have found that light
stimulates tyrosine phosphorylation of several proteins in rat ROS
in vivo (20). In addition, in vivo
light-dependent association of Src with ROS (21) and
light-mediated activation of diacylglycerol kinase in rat ROS have been
reported (22). In the present study, we demonstrate that light-induced
tyrosine phosphorylation of the insulin receptor in ROS in
vivo is involved in the regulation of PI3K activity in retina.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Polyclonal antisera to the p85
regulatory
subunit of PI3K, and
1- and
3-Na+-K+-ATPase were from Upstate
Biotechnology, Inc. (Lake Placid, NY). Polyclonal anti-IR
and
anti-Tyr(P) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Monoclonal anti-opsin antibody (Rho 4D2) was a gift from Dr. Robert
Molday (University of British Columbia). Mouse anti-opsin
was a gift of Dr. Colin Barnstable (Yale University). Anti-arrestin
antibody was a gift from Dr. James McGinnis (University of Oklahoma
Health Sciences Center). PY-20 antibody was from Transduction Laboratories (Lexington, KY). [
-32P]ATP was from
PerkinElmer Life Sciences. Echelon Research Laboratories Inc. (Salt
Lake City, UT) provided
D-myo-phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2). All other reagents were of analytical grade
from Sigma.
Preparation of Rat ROS--
Albino Sprague-Dawley rats were
dark-adapted overnight and sacrificed either under dim red light or
following 30 min of light exposure (300 lux). ROS were prepared on a
discontinuous sucrose gradient from either dark- or light-adapted
retinas as previously described (23) with some minor modifications
(21). Retinas were homogenized in 4.0 ml of 47% sucrose solution
containing 100 mM NaCl, 1 mM EDTA, 1 mM orthovanadate, 1 mM phenylmethylsulfonyl fluoride, and 10 mM Tris-HCl (pH 7.4) (buffer A). Retinal
homogenates were transferred to 15-ml centrifuge tubes and sequentially
overlaid with 3.0 ml of 42%, 3.0 ml of 37%, and 4.0 ml of 32%
sucrose dissolved in buffer A. The gradients were spun at 82,000 × g for 1 h at 4 °C. The 32%/37% interfacial
sucrose band containing ROS membranes was harvested; diluted with 10 mM Tris-HCl (pH 7.4) containing 100 mM NaCl, 1 mM EDTA, 1 mM orthovanadate (buffer B); and
centrifuged at 27,000 × g for 30 min. The ROS pellets
were resuspended in buffer B and stored at
20 °C. The non-ROS band
designated Band II (37%/42%) was also saved for comparison with ROS.
All procedures were carried out under dim red light for dark-adapted
retinas and in room light for light-adapted retinas. All protein
concentrations were determined by the BCA reagent from Pierce,
following the manufacturer's instructions.
Preparation of Bovine ROS and Retinal Pigment
Epithelium--
Fresh bovine eyes were obtained from a local abattoir
and placed on ice and retinas were dissected within 2 h. ROS were
prepared from fresh retinas on a continuous sucrose gradient (25-50%)
as previously described (19). Bovine retinal pigment epithelial cells
(RPE cells) were prepared according to the method described by Saari
et al. (24).
Immunoprecipitation (IP)--
Retinal lysates or ROS were
solubilized for 30 min at 4 °C in a lysis buffer containing 1%
Triton X-100, 137 mM NaCl, 20 mM Tris-HCl (pH
8.0), 10% glycerol, 1 mM EGTA, 1 mM
MgCl2, 1 mM phenylmethylsulfonyl fluoride, 0.2 mM Na3VO4, 10 µg/ml leupeptin,
and 1 µg/ml aprotinin. Insoluble material was removed by
centrifugation at 17,000 × g for 20 min, and the
solubilized proteins were precleared by incubation with 40 µl of
protein A-Sepharose for 1 h at 4 °C with mixing. The
supernatant was incubated with either anti-p85
(1:300),
anti-Tyr(P) (4 µg), or anti-IR
(4 µg) antibodies
overnight at 4 °C and subsequently with 40 µl of protein
A-Sepharose for 2 h at 4 °C. Immune complexes were washed twice
with modified solubilization buffer (the 1% Triton X-100 was reduced
to 0.1%, and glycerol was removed) and once with phosphorylation
buffer without ATP (19). Precipitates were assayed for PI3K activity or
subjected to immunoblot analysis.
SDS-PAGE and Western Blot Analysis--
Proteins were resolved
by 10% SDS-PAGE and transferred onto nitrocellulose membranes, and the
blots were washed two times for 10 min with TTBS (20 mM
Tris-HCl (pH 7.4), 100 mM NaCl, and 0.1% Tween 20) and
blocked with 10% bovine serum albumin in TTBS overnight at 4 °C.
Blots were then incubated with anti-p85
(1:4000), anti-IR
(1:1000), or anti-Tyr(P) (1:1000) antibodies for 2 h at room
temperature. Following primary antibody incubations, immunoblots were
incubated with horseradish peroxidase-linked secondary antibodies (either anti-rabbit, anti-mouse, or anti-Goat IgG) and developed by ECL
according to the manufacturer's instructions.
PI3K Assay--
Enzyme assays were carried out essentially as
previously described (25). Briefly, assays were performed directly on
immunoprecipitates in 50 µl of the reaction mixture containing 0.2 mg/ml PI-4,5-P2, 50 µM ATP, 0.2 µCi of
[
-32P]ATP, 5 mM MgCl2, and 10 mM HEPES buffer (pH 7.5). The reactions were carried out
for 15 min at room temperature and stopped by the addition of 100 µl
of 1 N HCl followed by 200 µl of chloroform/methanol (1/1, v/v). Lipids were extracted and resolved on oxalate-coated TLC
plates (silica gel 60) with a solvent system of 1-propanol, 2 M acetic acid (65/35, v/v). The plates were coated in 1%
(w/v) potassium oxalate in 50% (v/v) and then baked in oven at
100 °C for 1 h prior to use. TLC plates were exposed to x-ray
film overnight at
70 °C, and radioactive lipids were scraped and
quantified by liquid scintillation counting.
GST-p85 Fusion Proteins and Pull-down Experiments--
GST-p85
fusion proteins were generated by PCR amplification of the indicated
p85
regions and cloned into pGEX2T (Amersham Biosciences).
The amino acids of bovine p85
present in each fusion protein are
N-SH2 (residues 314-446) and C-SH2 (residues 614-724), based on the
sequence published by Otsu et al. (26). The sequence of each
clone was verified by DNA sequencing. All inductions yielded proteins
of the expected size as judged by Coomassie staining. Pull-down
experiments were carried out as described (19) using 5 µg of GST
fusion proteins that had been adsorbed onto glutathione-Sepharose 4B
matrix. ROS from dark- and light-adapted rats were incubated with
GST/GST-p85 fusion proteins at 4 °C for 1.5 h, with continuous mixing. The Sepharose beads were washed three times in 500 µl of HNTG
buffer (20 mM HEPES (pH 7.5), 150 mM NaCl,
0.1% Triton X-100, and 10% glycerol) and centrifuged at 5,000 rpm for
30-60 s at 4 °C. GST-p85 fusion proteins and bound proteins were
eluted by boiling in 2× SDS sample buffer 5 min prior to 10%
SDS-PAGE. After the SDS-PAGE, the gels were subjected to Western blot
analysis with anti-IR
antibody.
Site-directed Mutagenesis--
Site-directed mutagenesis was
carried out using a QuikChange site-directed mutagenesis kit
(Stratagene Inc., La Jolla, CA), using a PTC 100 programmable thermal
controller (MJ Research, Inc., Watertown, MA). The reaction mixture
contained site-directed mutagenesis buffer (200 mM Tris-HCl
(pH 8.8), 100 mM KCl, 100 mM
NH4SO4, 20 mM MgSO4,
1% Triton X-100, 1 mg/ml nuclease-free bovine serum albumin), 1 mM deoxynucleotide mix (dATP, dCTP, dTTP, and dGTP), 50 ng
of GST-pGEX vector containing either p85 (N-SH2) or p85 (C-SH2) fusion
proteins, and 125 ng of sense and antisense primers with mutations, in
a total volume of 50 µl, followed by the addition of 2.5 units of
Pfu DNA polymerase. The mutant primers were R358A (sense,
ACC TTT TTG GTA GCA GAC GCA TCT ACT AAA; antisense, TTT AGT AGA TGC GTC
TGC TAC CAA AAA GGT) and R649A (sense, ACT TTT CTT GTC GCG GAA AGC AGT
AAA CAG; antisense, CTG TTT ACT GCT TTC CGC GAC AAG AAA AGT). The
extension parameters of site-directed mutagenesis were as follows:
initial denaturation at 95 °C for 30 s, followed by 16 cycles
at 95 °C for 30 s, 55 °C for 1 min, and 68 °C for 12 min
(2 min/kb of plasmid length). Following temperature cycling, the
reaction was placed on ice for 2 min, after which 10 units of
DpnI restriction enzyme were added, mixed, and incubated at
37 °C for 60 min. Transformation was carried out using 1 µl of the
DpnI-treated reaction to Epicurean XL-blue supercompetent cells, and the reaction was placed on LB/Amp (100 µl/ml) plates. The
cDNAs of all mutants were sequenced after PCR; the only mutations observed were those intentionally introduced to create each desired mutation. The clones were induced with
isopropyl-1-thio-
-D-galactopyranoside (0.1 mM), and the expressed fusion proteins were purified
through GST-Sepharose 4B matrix.
In Vivo Light Experiments on Rats and Mice--
Albino
Sprague-Dawley rats (150-200 g) purchased from Harlan Sprague-Dawley
(Indianapolis, IN) were maintained for at least 2 weeks in dim cyclic
light (12 h on; 12 h off; 5-10 lux). A breeding colony of FVB/N
mice is maintained in our vivarium in cyclic light (12 h on; 12 h
off; ~400 lux). Light absorption by rhodopsin activates transducin, a
G-protein, which in turn promotes cGMP hydrolysis by
cGMP-phosphodiesterase, leading to hyperpolarization of rod photoreceptor cells (27). FVB/N mice are homozygous for the Pdebrd1 mutation (formally known as rd1) in the
cGMP-phosphodiesterase
-subunit. As a result, these mice undergo
rapid photoreceptor degeneration beginning at postnatal day 9 (28-31).
The retinas from adult FVB/N mice completely lack photoreceptors. On
the day of an experiment, rats or mice were dark-adapted overnight, and half were subjected to normal room light (~300 lux) for 30 min. Eyes
were enucleated, and the retinas were quickly removed and homogenized
by hand in homogenizing buffer (20 mM Tris-HCl (pH 7.4),
100 mM NaCl, 10% sucrose, 1 mM EDTA, 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 1 mM
phenylmethylsulfonyl fluoride). The retina lysates were either used
directly or for the preparation of ROS. The retina lysate or ROS was
immunoprecipitated with anti-IR
antibody, followed by either Western
blotting with anti-IR
or anti-Tyr(P) antibodies or measuring the
PI3K activity using PI-4,5-P2 as substrate. All animal work
was in strict accordance with the NIH Guide for the Care and Use
of Laboratory Animals, and the protocols were approved by the
IACUC of the University of Oklahoma Health Sciences Center and the Dean
A. McGee Eye Institute. The data were analyzed by Student's
t test, and statistical significance was set at
p < 0.05.
Immunolabeling of ROS and Whole Mount Preparations--
Intact
ROS, some containing blebs of inner segments attached through the
connecting cilium, were prepared by mechanical detachment from freshly
dissected bovine retinas, as a suspension in Hanks' balanced salt
solution (Sigma) buffered with 25 mM HEPES (pH 7.4) (32).
After gentle homogenization by five passes through a Pasteur pipette,
cell fragments in suspension were allowed to adsorb for 3 min to a
VectbondTM (Vector Laboratories, Burlingame, CA)-treated
glass slide. Adhered cell fragments were fixed for 5 min in methanol at
20 °C and washed three times with PBS before processing for
immunostaining. To detect IR
in the dissociated photoreceptors,
slides were incubated with a mixture of mouse anti-IR
(GR36;
Calbiochem) and rabbit-anti-transducin
(SC-389; Santa Cruz
Biotechnology) diluted 1:1000 and 1:800, respectively, in PBS
containing 10% horse serum. The transducin
antibody was included
to clearly identify intact ROS. To determine whether the anti-IR
was
specific, an identical antibody mixture was incubated with a blocking
IR
peptide antigen (SC-711P; Santa Cruz Biotechnology) for 24 h
at 4 °C before incubation on the isolated photoreceptors. To
demonstrate that the blocking peptide was specific to IR
, additional
slides were incubated with an antibody mixture containing mouse
anti-opsin, rabbit anti-transducin
, and the IR
blocking peptide,
diluted 1:100, 1:800, and 1:200, respectively. Antibodies were
incubated overnight at 4 °C and then washed with PBS. For
fluorescent detection, slides were incubated with a mixture of Texas
Red-anti-mouse and fluorescein isothiocyanate-anti-rabbit antibodies
(Vector Laboratories), each diluted 1:200 in PBS with 10% horse serum.
Following incubation for 1 h at room temperature, the slides were
washed with phosphate-buffered saline and cover-slipped in 50%
glycerol in phosphate-buffered saline. Antibody-labeled complexes were
examined on a Nikon Eclipse E800 microscope equipped with a digital
camera, and images were captured using Metamorph (Universal Imaging,
West Chester, PA) image analysis software. For quantitation, all images
were captured using identical microscope and camera setting, so that
intensities of the digital images quantitatively reflect antibody binding.
 |
RESULTS |
Increased PI3K Activity Associated with Anti-Tyr(P) but Not with
Anti-p85 IPs--
To determine whether light has an effect on PI3K
activity and the phosphorylation of the insulin receptor, rats were
dark-adapted overnight, and half were subjected to normal room light
for 30 min. Retinas were removed quickly and homogenized, and lysates were immunoprecipitated with anti-Tyr(P) or anti-p85 antibodies. PI3K
enzyme activity was higher in anti-Tyr(P) IPs from whole retinas (Fig.
1A) and ROS (Fig.
1B) from light-adapted (L) rats, compared with
those from dark-adapted (D) animals. In contrast, only a
marginal increase in PI3K activity was observed in anti-p85 IPs of
light-adapted retinas over dark-adapted retinas (Fig. 1C), suggesting that light may induce the translocation of PI3K from cytoplasm to tyrosine-phosphorylated proteins in the disk membrane.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
PI3K enzyme activity was measured in the
anti-Tyr(P) (A) or anti-p85 (C)
immunoprecipitates (50-100 µg of protein) from
dark- or light-adapted rat retina homogenates or ROS membranes
immunoprecipitated with anti-Tyr(P) (PY) antibodies
(B). PI3K activity was measured using
PI-4,5-P2 and [ 32P]ATP as substrates. The
radioactive spots of PI-3,4,5-P3 were scraped from the TLC
plate and counted. Data are means ± S.D. (n = 3).
L, light; D, dark.
|
|
Increased IR
Phosphorylation, p85 Association, and PI3K Enzyme
Activity Associated with anti-IR
IPs of Light-adapted Rat
Retinas--
When retinal homogenates were immunoprecipitated with
anti-IR
antibodies, PI3K activity was more than 4-fold higher in IPs from light-adapted rats compared with those from dark-adapted animals
(Fig. 2, D and E).
Western blot analysis of anti-IR
IPs probed with anti-IR
antibody
indicated an equal amount of IR
in both light- and dark-adapted rat
retinas (Fig. 2A). However, anti-IR
IPs probed with
anti-Tyr(P) (Fig. 2B) and anti-p85 (Fig. 2C)
antibodies showed almost 2-fold greater phosphorylation of IR
(quantitative analysis of bands was carried out using Image software
1.62 (National Institutes of Health; available on the World Wide Web at
rsb.info.nih.gov/nih-image/download.html) in light-adapted rat retinas
and binding of p85, respectively. These results demonstrate
light-induced phosphorylation of the IR
, as well as light-induced
binding of p85 to the insulin receptor.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 2.
In vivo light-dependent
phosphorylation of IR . Rats (six per group) were either dark-
or light-adapted as described under "Experimental Procedures."
Retinas from each rat were pooled, homogenized, immunoprecipitated with
anti-IR antibodies, and immunoblotted with anti-IR
(A), anti-Tyr(P) (B), or anti-p85 antibodies
(C) or measured for PI3K activity using
PI-4,5-P2 and [ -32P]ATP as substrates
(D). E, the radioactive spots of
PI-3,4,5-P3 were scraped from the TLC plate and counted.
Data are means ± S.E. (n = 6). The difference
between light and dark PI3K activity is significant at
p < 0.01. WB, Western blot.
|
|
Light-dependent Association of p85 with ROS
Membranes--
ROS membranes that were prepared on a discontinuous
sucrose density gradient showed a greater PI3K enzyme activity in
light-adapted rats compared with dark-adapted rats (Fig.
3D). Western blot analysis indicated an increased amount of p85 in light-adapted ROS compared with
dark-adapted ROS (Fig. 3A). The photoreceptor-specific
protein opsin was used as internal control and indicated that an equal amount of protein was used in these analyses (Fig. 3C).
Arrestin is known to move from the inner segment to outer segment in
light (33, 34), and its accumulation in the ROS was a positive control to verify that the retinas responded to light in a predictable manner
(Fig. 3B). These in vivo studies demonstrate the
light-induced tyrosine phosphorylation of IR
and the subsequent
association of PI3K in ROS.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 3.
PI3K activity and expression of p85
(A), arrestin (B), and opsin
(C) in dark- and light- adapted rat ROS (20 µg of protein). PI3K activity was measured in
50 µg of light- or dark-adapted ROS protein. The radioactive spots of
PI-3,4,5-P3 were scraped from the TLC plate and counted
(D). Data are means ± S.D. (n = 3).
|
|
Binding of Light-induced Tyrosine-phosphorylated Insulin Receptor
to GST-p85 (N-SH2) Fusion Proteins--
Rats were dark-adapted
overnight, and half were subjected to normal room light for 30 min.
Retinas were quickly removed and homogenized, and ROS were prepared by
discontinuous sucrose density gradient centrifugation. Solubilized
light- and dark-adapted rat ROS were incubated with GST-p85 (N-SH2) or
mutant p85 (N-SH2, R358A) fusion proteins and subjected to GST
pull-down assays. The bound proteins were run on 8% SDS-PAGE and
probed with anti-IR
antibodies. IR
did not bind to the GST
controls (Fig. 4, lanes 1 and 2) but did bind to the GST-p85 (N-SH2)
fusion protein. Quantitatively, more IR
was pulled down from
light-adapted ROS than from dark-adapted ROS (lanes
3 and 4). Mutating Arg-358 in p85 to Ala-358
abolished all binding (lanes 5 and 6),
demonstrating the requirement for the native N-SH2 motif. Western blots
of the ROS preparations using the anti-IR
antibody showed the
presence of the insulin receptor in the membranes (lanes
7 and 8). Since p85 only interacts with
phosphorylated IR
, these results further confirm the light-induced tyrosine phosphorylation of IR
in vivo. Since our
previous studies had shown that C terminus SH2 and its mutant version
(R649A) did not interact with bovine retinal IR
in vitro
(19), we did not test these fusion proteins in vivo.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
GST pull-down experiments. Light- and
dark-adapted ROS (50 µg each) were incubated with GST, GST-p85, or
GST-p85 (R358A) fusion proteins, followed by Western blot analysis of
the bound proteins with anti-IR antibody. Ten µg of light- or
dark-adapted ROS were directly loaded to assess equal amounts of IR
in light- and dark-adapted conditions. Lanes 1,
3, 5, and 7, light-adapted;
lanes 2, 4, 6, and
8, dark-adapted.
|
|
Role of Insulin in the Activation of the Retinal Insulin
Receptor--
To assess the role of insulin in retinal IR
phosphorylation, we measured IR
activation in rats that were made
insulin-deficient by the injection of streptozotocin. The state of
diabetes was confirmed by measuring blood glucose levels (35). Retinas
were removed from hyperglycemic (insulin-deficient animals) and control animals in normal room light. Samples were lysed in homogenizing buffer
and subjected to immunoprecipitation with anti-IR
antibody. PI3K
activity and the phosphorylation of IR
were examined in the IPs.
There was no difference in the PI3K activity (Fig.
5B) or the degree of IR
phosphorylation (Fig. 5A) in control and insulin-deficient
rats. These studies suggest that whereas insulin may be sufficient to
activate insulin receptors in isolated ROS in vitro (19, 36,
37), it may not be required for the light-dependent activation of IR
in vivo.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
PI3K activity and phosphorylation of
IR in control and diabetic rat retinas.
One hundred µg of protein was immunoprecipitated with anti-IR
antibody and subjected to either Western blotting (WB)
analysis with anti-Tyr(P) antibody (A) or measuring PI3K
activity (B) using PI-4,5-P2 and
[ -32P]ATP as substrates. The radioactive spots of
PI-3,4,5-P3 were scraped from the TLC plate and counted
(B). Data are mean ± S.D. (n = 4).
|
|
Location of Insulin Receptors in the Retina--
We verified the
presence of the insulin receptor in ROS by several approaches, to
eliminate the possibility that our ROS preparations were contaminated
with inner segment or RPE membranes. RPE cells were obtained from fresh
bovine eyes, and ROS and Band II retinal membranes were prepared from
light-adapted rat retinas by discontinuous sucrose gradient
centrifugation. Western blots of the three preparations were probed
with two marker enzymes, the
1 and
3 isoforms of Na+-K+-ATPase. The
1 isoform is mainly
present in RPE cells, whereas
3 is mainly found in inner segments;
neither is present in ROS (38). As shown in Fig.
6, the
1 isoform was present in RPE (lane 1) and Band II (lane
3) but not in the ROS fraction (lane 2). The
3 isoform
was absent from RPE (lane 1) and rat ROS
(lane 2) but was present in Band II from rat
retina (lane 3). Similar blots probed with the
anti-IR
antibody indicated the presence of insulin receptors in all
fractions (Fig. 6).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 6.
Western blot (WB) analysis
of
1-Na+-K+-ATPase,
3-Na+-K+-ATPase, and
IR expression in bovine RPE and rat ROS.
Twenty µg of bovine RPE and 20 µg of rat ROS membranes prepared on
a discontinuous sucrose density gradient from light- and dark-adapted
retinas were probed for 1-Na+-K+-ATPase,
3-Na+-K+-ATPase, and IR expression
employing respective antibodies. Lane 1, bovine
RPE; lane 2, rat ROS; lane
3, rat non-ROS membranes (Band II).
|
|
To further demonstrate that insulin receptors are present in
photoreceptor outer segments, we immunolabeled bovine ROS (containing some attached inner segment) with an anti-IR
antibody.
Immunostaining was found in both outer and inner segments (Fig.
7A). Inclusion of the
IR
-blocking peptide inhibited the immunoreactivity of IR
(Fig.
7B). Photoreceptors were identified by the expression of
transducin
(Fig. 7, D-F). The blocking peptide did not
block the binding of the anti-opsin antibody (Fig. 7C) or
the anti-transducin antibody (Fig. 7, E and F).
These results provide strong evidence that the insulin receptor is
present in ROS membranes.

View larger version (90K):
[in this window]
[in a new window]
|
Fig. 7.
Immunolocalization of IR
in dissociated ROS. Bovine ROS were prepared on glass slides
as described under "Experimental Procedures." Immunolabeling with
transducin (D-F) was used to identify ROS. The
co-localization of IR (A) and transducin (D) clearly demonstrates the presence of IR in rod
photoreceptors. The immunostaining of IR was significantly
blocked using the peptide from which the antibody was generated
(B). The same peptide did not block transducin staining
(E and F), nor did it block the anti-opsin
antibody (C).
|
|
Co-localization of IR
with Opsin--
A third approach was
taken to demonstrate the presence of the insulin receptor in rod outer
segments. Bovine ROS were prepared on a continuous sucrose density
gradient and further purified on a second gradient (18). Serial 1.0-ml
fractions were collected and analyzed for opsin (Fig.
8D), p85 (Fig. 8B),
and IR
(Fig. 8A). PI3K enzyme activity was measured in
anti-IR
immunoprecipitates (Fig. 8C). Western blot
analysis of IR
indicated its presence predominantly in the fractions
containing the largest concentration of opsin (ROS fractions). PI3K
activity in the immunoprecipitates of anti-IR
was also highest in
the major opsin and IR
fractions. These results provide additional
evidence that insulin receptors are localized in the rod outer
segments.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 8.
Co-elution of ROS protein from continuous
sucrose density gradient centrifugation. Bovine ROS were further
purified by a second sucrose density gradient centrifugation. Each
fraction was subjected to SDS-PAGE followed by silver staining for the
detection of opsin (D). Individual fractions were subjected
to either immunoprecipitation with anti-IR antibody followed by
measurement of PI3K enzyme activity (C) or subjected to
Western blotting analysis for the detection of IR (A) and
p85 (B).
|
|
Role of Photobleachable Visual Pigments in the Activation of
PI3K--
Experiments were carried out on wild type and mutant mice to
investigate the involvement of photobleachable visual pigments in the
regulation of PI3K activity. As previously shown in rat retinas (Fig.
1-3), PI3K activity was significantly higher in anti-IR
IPs of
light-adapted wild type mouse retinas compared with dark-adapted mouse
retinas (Fig. 9A). However,
there was no difference in PI3K activity in light- and dark-adapted
Pdeb(rd) mutant mice (FVB), which lack photoreceptors (Fig.
9B). Lack of photoreceptors was confirmed by probing the
retina lysates with an anti-opsin antibody, where no detectable opsin
was observed (Fig. 9D), compared with wild type mouse retina
(Fig. 9C). Probing the FVB mouse retinas for IR
expression indicated the presence of IR
(Fig. 9E),
demonstrating that IR
is also present in retina cells other than
photoreceptors. The results suggest that the observed light/dark
differences in IR
phosphorylation and subsequent binding of PI3K are
photoreceptor-specific phenomenon that are probably mediated by photon
capture in the ROS. In Fig. 9E, we have observed two IR
bands in mouse retina lysate. The bottom band could be a proteolytic
degradation of 97-kDa IR
(top band) or an IR
isoform.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 9.
PI3K activity, opsin, and
IR expression in retinas of wild type and FVB
mice. PI3K activity was measured in the immunoprecipitates of
IR from 100 µg of (A) wild type
(n = 9) and (B) FVB (n = 4)
mouse retinas. Data are means ± S.E. *, p < 0.05. D, dark; L, light. Opsin expression was
examined with 10 µg of protein from light- and dark-adapted wild type
(C) and FVB mice (D). IR (E)
expression (10 µg) was examined only from light-adapted wild type and
FVB mice.
|
|
 |
DISCUSSION |
In the current study, we have made two novel findings that are
likely to be functionally significant in photoreceptors. We have
demonstrated light-dependent tyrosine phosphorylation of IR
in ROS, and we have shown the association of PI3K enzyme activity with the activated receptor only in rod outer segments stimulated by
light. The association of PI3K and IR
is dependent on tyrosine phosphorylation. We have previously reported that light stimulates tyrosine phosphorylation of multiple proteins in ROS in vivo
(20). In the current study, we have demonstrated that one of the
targets is the IR
and that this phosphorylation leads to the
association of PI3K activity with ROS membranes. The increased PI3K
activity could have been due to increased p85 expression or to
translocation of PI3K from the cytoplasm to the ROS membranes. To
distinguish between these possibilities, we measured PI3K activity in
anti-p85 immunoprecipitates of retinal homogenates and in isolated ROS membranes. Total PI3K activity was not significantly different between
light- and dark-adapted anti-p85 precipitates from homogenates but was
increased in isolated ROS. Therefore, the increased activity of PI3K
associated with IR
in light-adapted ROS is the result of PI3K
translocation from the cytoplasm to the membrane. Previous studies from
our laboratory using radiolabeled inositol have shown that the enzymes
for PI-4,5-P2 synthesis are present in bovine ROS. Further,
light adaptation of bovine retinas in situ stimulates phosphatidylinositol (PI) synthesis in rod outer segments (39). These
studies indicate an active PI cycle in rod outer segments that
can provide the substrate PI-4,5-P2 for phosphorylation by PI3K.
We have localized the activation of IR
to retinal photoreceptors
using biochemical, genetic, and immunolocalization approaches. First,
we identified IR
in highly enriched ROS that lack markers for rod
inner segments and RPE. Second, in adult mice homozygous for the Pdeb
(RD) mutation that lack rods and cones, we failed to observe
light-dependent activation of IR
or increased PI3K activity. These experiments also indicate that the light response requires functional photoreceptor cells. This result excludes the
possibility that the light-dependent activation occurs in photopigment-expressing ganglion cells, inner retinal neurons, or RPE
(40, 41). Third, we have immunolocalized the expression of IR
to rod
photoreceptor cells. Combined, these data provide compelling evidence
that the light-dependent activation of IR
is occurring
in photoreceptor outer segments.
Our results demonstrate that light stimulates tyrosine phosphorylation
of ROS proteins including IR
, which promotes the binding of the p85
regulatory subunit of PI3K to the ROS membranes. The mechanism for
light-induced phosphorylation of IR
and subsequent activation of
PI3K is not known. Several studies have shown that the
-subunit of
the insulin receptor is present in ROS and can be phosphorylated in
response to insulin (19, 36, 37). Insulin activates PI3K in many other
tissues (42), including cultured retinal neurons (43). However, it
appears unlikely that insulin is involved in IR
activation in the
retina in vivo, since insulin does not cross the
blood-retinal barrier (44), and our studies on diabetic animals
indicate that light-dependent phosphorylation of
IR
is not insulin-dependent.
We speculate that there could be two possible mechanisms that trigger
the phosphorylation of IR
. One could involve ligand(s) other than
insulin, which are induced in response to light and bind to IR
.
There are no data to support this notion, although this does not
preclude activated transducin or some other participant in the visual
transduction cascade playing an important role in this process. This
point will be addressed in subsequent studies using mice with specific
mutations in genes expressing proteins involved in visual transduction.
The second mechanism involves the activation of a nonreceptor tyrosine
kinase(s) in response to light. It has been shown that the nonreceptor
tyrosine kinase Src phosphorylates insulin- and insulin-like growth
factor receptors on autophosphorylation sites (45, 46). Thus, the Src
kinase has been shown to substitute for the
ligand-dependent receptor activation (44, 45). It has
recently been shown that c-Src associates with light-activated opsin
(21). Together, these results suggest a model where the light
activation of opsin results in its association with c-Src, which in
turn associates with and activates the insulin receptor. Consistent
with this mechanism, we have also reported previously the in
vitro phosphorylation of IR
by c-Src in ROS (19).
In addition to activation of the phototransduction cascade, light is
known to cause the activation and regulation of several genes,
including those that regulate circadian rhythms (47). Light has been
shown to regulate retinal dopamine biosynthesis and tyrosine
hydroxylase activity (48), apoptosis (49), and intracellular
trafficking of photoreceptors in plants (50). Increasing evidence from
several laboratories suggests that normal light triggers the tyrosine
phosphorylation of several proteins. Nakahata et al. (51)
have reported the light-induced tyrosine phosphorylation of BIT
(brain immunoglobulin-like molecule with tyrosine-based activation motifs) protein in rat
suprachiasmatic nucleus, which resulted in its association with
nonreceptor tyrosine phosphatases, SHIP-1 and SHIP-2, which have two
SH2 domains (51). Tyrosine phosphorylation of MAP kinase-like protein
kinase has been activated by light in soybean cell cultures (52). The
mitogen-activated protein kinase cascade can be activated by brief
exposure to light during subjective night in the mouse suprachiasmatic
nucleus (53). It has also been reported that light-induced
photoreceptor apoptosis in vivo through the involvement
of neuronal nitric-oxide synthase and guanylate cyclase activity
independent of caspase-3 (54).
The functional consequence of light-dependent activation of
the IR
and PI3K in photoreceptor cells is not known. Activation of
the IR signaling pathway has been shown to have complex physiological roles in a variety of cell types (55). In rods, IR
activity is
regulated by light, which suggests that its function could be related
to rod-specific activities that are driven by light such as shedding of
photoreceptor tips (56), biogenesis of new ROS membranes through the
addition of newly synthesized membranes at the base of the ROS (57), or
light adaptation (58). Alternatively, it is possible that light-induced
PI3K activity may mediate an innate self-protection mechanism. In some
neuronal cell types, such as cerebellar granular neurons (59) and PC-12
cells (60), receptor activation of PI3K has been shown to protect these
cells from stress-induced neurodegeneration. It has been well
established that PI3K/c-Akt is crucial in mediating cell survival.
Since bright light stimulation can cause the death of rod and cone
photoreceptor cells (61, 62), activation of the PI3K/c-Akt pathway by
relatively modest light levels may serve to prevent death of
photoreceptors. Consistent with this hypothesis, we have recently
observed that biotinylated 3,4,5-PIP3 could pull down Akt
from bovine ROS,2 suggesting
that light-induced PI3K activity could regulate downstream effector
molecules. Understanding the regulation of PI3K in photoreceptor cells
will greatly facilitate studies on the regulation of downstream targets
that may reveal a role for PI3K in protection from retinal degeneration. Whether PI3K activation protects the retina from stress
is currently under study in our laboratory.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. Yashige Kotake
(Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma) for
providing diabetic rats. We thank Mark Dittmar for outstanding
assistance in managing and maintaining the animal colonies.
 |
FOOTNOTES |
*
This work was supported by NEI, National Institutes of
Health, Grants EY00871, EY04149, and EY12190; Research to Prevent
Blindness Inc. (New York, NY); The Foundation Fighting Blindness
(Baltimore, MD); the Samuel Roberts Nobel Foundation, Inc. (Ardmore,
OK); Presbyterian Health Foundation (Oklahoma City, OK); the Oklahoma Center for Advancement of Science and Technology (Oklahoma City, OK);
and the Knights Templar Eye Foundation (Chicago, IL).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: 608 Stanton L. Young Blvd., Rm. 409, Oklahoma City, OK 73104. Tel.: 405-271-8255; Fax:
405-271-8128; E-mail: raju-rajala@ouhsc.edu.
Published, JBC Papers in Press, September 3, 2002, DOI 10.1074/jbc.M206355200
2
R. V. S. Rajala and R. E. Anderson, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
SH2 and SH3, Src
homology 2 and 3, respectively;
PI3K, phosphoinositide 3-kinase;
GST, glutathione S-transferase;
IR
, insulin receptor
subunit;
ROS, rod outer segment(s);
IP, immunoprecipitate;
PI-4, 5-P2, phosphatidylinositol 4,5-bisphosphate;
PI-3, 4,5-P3, phosphatidylinositol 3,4,5-trisphosphate;
RPE, retinal pigment epithelium.
 |
REFERENCES |
| 1.
|
Schlessinger, J.
(2000)
Cell
103,
211-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Pawson, T.,
and Nash, P.
(2000)
Genes Dev.
14,
1027-1047[Free Full Text]
|
| 3.
|
Anderson, D.,
Koch, C. A.,
Grey, L.,
Ellis, C.,
Moran, M. F.,
and Pawson, T.
(1990)
Science
250,
979-982[Abstract/Free Full Text]
|
| 4.
|
Koch, C. A.,
Anderson, D.,
Moran, M. F.,
Ellis, C.,
and Pawson, T.
(1991)
Science
252,
668-674[Abstract/Free Full Text]
|
| 5.
|
McGlade, C. J.,
Ellis, C.,
Reedijk, M.,
Anderson, D.,
Mbamalu, G.,
Reith, A. D.,
Panayotou, G.,
End, P.,
Bernstein, A.,
Kazlauskas, A.,
Waterfield, M. D.,
and Pawson, T.
(1992)
Mol. Cell. Biol.
12,
991-997[Abstract/Free Full Text]
|
| 6.
|
Carpenter, C. L.,
Duckworth, B. C.,
Augers, K. R.,
Cohen, B.,
Schaffhausen, B. S.,
and Cantley, L. C.
(1990)
J. Biol. Chem.
265,
19704-19711[Abstract/Free Full Text]
|
| 7.
|
Dhand, R.,
Hiles, I.,
Panayotou, G.,
Roche, S.,
Fry, M. J.,
Gout, I.,
Totty, N. F.,
Truong, O.,
Vicendo, P.,
Yonezawa, K.,
Kasuga, M.,
Courtneidge, S. A.,
and Waterfield, M. D.
(1994)
EMBO J.
13,
522-533[Medline]
[Order article via Infotrieve]
|
| 8.
|
Skolnik, E. Y.,
Margolis, B.,
Mohammadi, M.,
Lowenstein, E.,
Fischer, R.,
Drepps, A.,
Ullrich, A.,
and Schlessinger, J.
(1991)
Cell
65,
83-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Yoakim, M.,
Hou, W.,
Liu, Y.,
Carpenter, C. L.,
Kapeller, R.,
and Schaffhausen, B. S.
(1992)
J. Virol.
66,
5485-5491[Abstract/Free Full Text]
|
| 10.
|
Whitman, H.,
Downes, C. P.,
Keeler, M.,
Keller, T.,
and Cantley, L. C.
(1988)
Nature
332,
644-646[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Williams, L. T.
(1989)
Science
243,
1564-1570[Abstract/Free Full Text]
|
| 12.
|
Hu, P.,
Mondino, A.,
Skolnik, E. Y.,
and Schlessinger, J.
(1993)
Mol. Cell. Biol.
13,
7677-7688[Abstract/Free Full Text]
|
| 13.
|
Klippel, A.,
Escobedo, J. A.,
Fantl, W. J.,
and Williams, L. T.
(1992)
Mol. Cell. Biol.
12,
1451-1459[Abstract/Free Full Text]
|
| 14.
|
Fruman, D. A.,
Meyers, R. E.,
and Cantley, L. C.
(1998)
Annu. Rev. Biochem.
67,
481-507[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Fry, M. T.
(1994)
Biochim. Biophys. Acta.
1226,
237-268[Medline]
[Order article via Infotrieve]
|
| 16.
|
Martin, T. F. J.
(1998)
Annu. Rev. Cell Dev. Biol.
14,
231-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Guo, X. X.,
Ghalayini, A. J.,
Chen, H. M.,
and Anderson, R. E.
(1997)
Invest. Ophthalmol. Vis. Sci.
38,
1873-1882[Abstract/Free Full Text]
|
| 18.
|
Guo, X. X.,
Huang, Z.,
Bell, M. W.,
Chen, H.,
and Anderson, R. E.
(2000)
Mol. Vis.
6,
216-221[Medline]
[Order article via Infotrieve]
|
| 19.
|
Rajala, R. V. S.,
and Anderson, R. E.
(2001)
Invest. Ophthal. Vis. Sci.
42,
3110-3117[Abstract/Free Full Text]
|
| 20.
|
Ghalayini, A. J.,
Guo, X. X.,
Koutz, C. A.,
and Anderson, R. E.
(1998)
Exp. Eye Res.
66,
817-821[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Ghalayini, A. J.,
Desai, N.,
Smith, K. R.,
Holbrook, R. M.,
Elliott, M. H.,
and Kawakatsu, H.
(2002)
J. Biol. Chem.
277,
1469-1476[Abstract/Free Full Text]
|
| 22.
|
Huang, Z.,
Ghalayini, A. J.,
Guo, X. X.,
Alvarez, K. M.,
and Anderson, R. E.
(2000)
J. Neurochem.
75,
355-362[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Organisciak, D. T.,
Xie, A.,
Wang, H. M.,
Jiang, Y. L.,
Darow, R. M.,
and Donoso, L. A.
(1991)
Exp. Eye Res.
503,
773-779
|
| 24.
|
Saari, J. C.,
Bunt, A. H.,
Futterman, S.,
and Berman, E. R.
(1977)
Invest. Ophthalmol. Vis. Sci.
16,
797-806[Abstract/Free Full Text]
|
| 25.
|
Kaplan, D. R,
Whitman, M.,
Schaffhausen, B.,
Pallas, D. C.,
White, M.,
Cantley, L. C.,
and Roberts, T. M.
(1987)
Cell
50,
1021-1029[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Otsu, M.,
Hiles, I.,
Gout, I.,
Fry, M. J.,
Ruiz-Larrea, F.,
Panayotou, G.,
Thompson, A.,
Dhand, R.,
Hsuan, J.,
and Totty, N.
(1991)
Cell
65,
91-104[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Roof, D.,
and Makino, C. L.
(2000)
Principles and Practice of Ophthalmology
, W. B. Saunders Co., Philadelphia
|
| 28.
|
Sidman, R. L.,
and Green, M. C.
(1965)
J. Hered.
56,
23-29[Free Full Text]
|
| 29.
|
Bowes, C., Li, T.,
Danciger, M.,
Baxter, L. C.,
Applebury, M. L.,
and Farber, D. B.
(1990)
Nature
347,
677-680[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Pittler, S. J.,
and Baehr, W.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8322-8326[Abstract/Free Full Text]
|
| 31.
|
Lem, J.,
Flannery, J. G., Li, T.,
Applebury, M. L.,
Farber, D. B.,
and Simon, M. I.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4422-4426[Abstract/Free Full Text]
|
| 32.
|
Muresan, V.,
Joshi, H. C.,
and Besharse, J. C.
(1993)
J. Cell Sci.
104,
1229-1237[Abstract]
|
| 33.
|
McGinnis, J. F.,
Matsumoto, B.,
Whelan, J. P.,
and Cao, W.
(2002)
J. Neurosci. Res.
67,
290-297[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Whelan, J. P.,
and McGinnis, J. F.
(1988)
J. Neurosci. Res.
20,
263-2710[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Tabatabaie, T.,
Waldon, A. M.,
Jacob, J. M.,
Floyd, R. A.,
and Kotake, Y.
(2000)
Biochem. Biophys. Res. Commun.
273,
699-704[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Waldbillig, R. J.,
Fletcher, R. T.,
Chader, G. J.,
Rajagopalan, S.,
Rodrigues, M.,
and LeRoith, D.
(1987)
Exp. Eye Res.
45,
837-844[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Waldbillig, R. J.,
Fletcher, R. T.,
Chader, G. J.,
Rajagopalan, S.,
Rodrigues, M.,
and LeRoith, D.
(1987)
Exp. Eye Res.
45,
823-835[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Wetzel, R. K.,
Arystarkhova, E.,
and Sweadner, K. J.
(1999)
J. Neurosci.
19,
9878-9889[Abstract/Free Full Text]
|
| 39.
|
Ghalayini, A. J.,
and Anderson, R. E.
(1995)
Curr. Eye Res.
14,
1025-1029[Medline]
[Order article via Infotrieve]
|
| 40.
|
Miyamoto, Y.,
and Sancar, A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6097-6102[Abstract/Free Full Text]
|
| 41.
|
Hao, W.,
and Fong, H. K. W.
(1999)
J. Biol. Chem.
274,
6085-6090[Abstract/Free Full Text]
|
| 42.
|
Ruderman, N. B,
Kapeller, R.,
White, M. F,
and Cantley, L. C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
1411-1415[Abstract/Free Full Text]
|
| 43.
|
Barber, A. J.,
Nakamura, M.,
Wolpert, E. B.,
Reiter, C. E. N.,
Seigel, G. M.,
Antonetti, D. A.,
and Gardner, T. W.
(2001)
J. Biol. Chem.
27,
32814-32821
|
| 44.
|
James, C. R.,
and Cotlier, E.
(1983)
Br. J. Ophthalmol.
67,
80-88[Abstract/Free Full Text]
|
| 45.
|
Yu, K. T.,
Werth, D. K.,
Pastan, I. H.,
and Czech, M. P.
(1985)
J. Biol. Chem.
260,
5838-5846[Abstract/Free Full Text]
|
| 46.
|
Peterson, J. E.,
Kulik, G.,
Jelinek, T.,
Reuter, C. W.,
Shannon, J. A.,
and Weber, M. J.
(1996)
J. Biol. Chem.
271,
31562-31572[Abstract/Free Full Text]
|
| 47.
|
Kramer, R. H.,
and Molokanova, E.
(2001)
J. Exp. Biol.
204,
2921-2931[Abstract/Free Full Text]
|
| 48.
|
Iuvone, P. M.
(1984)
Fed. Proc.
43,
2709-2713[Medline]
[Order article via Infotrieve]
|
| 49.
|
Hafezi, F.,
Marti, A.,
Munz, K.,
and Reme, C. E.
(1997)
Exp. Eye Res.
64,
963-970[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Nagy, F.,
Kircher, S.,
and Schafer, E.
(2001)
J. Cell Sci.
114,
475-480[Abstract]
|
| 51.
|
Nakahata, Y.,
Okumura, N.,
Shima, T.,
Okada, M.,
and Nagai, K.
(2000)
J. Neurochem.
74,
2436-2444[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Yamagata, H.,
Saka, K.,
Tanaka, T.,
and Aizono, Y.
(2001)
FEBS Lett.
494,
24-29[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Obrietan, K.,
Impey, S.,
and Storm, J. S.
(1998)
Nat. Neurosci.
1,
693-700[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Donovan, M.,
Carmody, R. J.,
and Cotter, T. G.
(2001)
J. Biol. Chem.
276,
23000-23008[Abstract/Free Full Text]
|
| 55.
|
Saltiel, A. R.,
and Pessin, J. E.
(2002)
Trends Cell Biol.
12,
65-71[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Basinger, S.,
Hoffman, R |